24
Copyright 1998 Waters Corporation HPLC Determination of Antidepressants and their Metabolites in Plasma <XQJ)RQJ&KHQJ , Laura Bean, Edouard S. P. Bouvier, Mark Capparella, Pamela Iraneta, Andy Jarrell, Uwe D. Neue, Dorothy J. Phillips, and Doug Wittmer Waters Corporation, 34 Maple Street, Milford, MA 01757

HPLC Determination of Antidepressants and their ...Validated Method for Analysis of Enalapril in Human Plasma Concentration % Recovery n=6 Interday Precision, %CV n= 5 (x 2) Intraday

  • Upload
    others

  • View
    2

  • Download
    0

Embed Size (px)

Citation preview

  • Copyright 1998 Waters Corporation

    HPLC Determination of Antidepressants and their

    Metabolites in Plasma

  • Copyright 1998 Waters Corporation

    AbstractUsing the one-dimensional SPE method, we were able to obtain very high recoveries (all greater than 86%) and excellent reproducibility (all less than 5.0%) for a wide range of drugs. These compounds included acids, neutrals, and basesUsing the two-dimensional SPE method, we were able to selectively isolate analytes of interest from a complex sample matrix while eliminating almost all interferences.

  • “water loving”Provides the correct wetting property to keep the surface of the packing solvated even when the cartridges run dry

    “fat loving”Provides reversed-phase property for analyte retention

    Hydrophilicmonomer

    Lipophilicmonomer

    N O

    Two Unique Properties Are Carefully Balanced

    Reference: "A Novel Polymeric Reversed-Phase Sorbent for Solid-Phase Extraction," LC•GC Int. 10 (9)E.S.P. Bouvier, D.M. Martin, P.C. Iraneta, M. Capparella, Y. Cheng, and D.J. Phillips

    Oasis™ HLB SorbentHydro philic-Li pophilic Balanced

  • Copyright 1998 Waters Corporation

    Drying Effect on Recovery: C18 vs. Oasis™ HLB Cartridges

    3URFDLQDPLGH

    $FHWDPLQRSKHQ

    5DQLWLGLQH

    3URSUDQRORO

    'R[HSLQ

    ��

    ��

    ��

    ��

    ���

    � � �

    3HUFHQWUHFR

    YHU\

    'U\LQJ 7LPH�PLQXWHV�

    ��

    ��

    ��

    ��

    ���

    � � ��'U\LQJ 7LPH�PLQXWHV�

    C18 (1cc/100mg) HLB (1cc/30mg)

    * No Impact of Sorbent Drying

    * No Silanol Interaction

    * No Breakthroughof Polar Analyte

    Bouvier, Capparella

  • Copyright 1998 Waters Corporation

    One-Dimensional SPE Method

    Simple, Rugged, and Highly Reproducible

    One General SPE Method for a Wide Range of Compounds

    Condition/Equilibrate1 mL methanol/1 mL water

    Load1 mL spiked sample

    Wash1 mL 5% methanol in water

    Elute1 mL methanol

    Evaporate and ReconstituteEvaporate and Reconstitute

    Prepare Sample Solution

  • Copyright 1998 Waters Corporation

    O

    CHCH2CH2N(CH3)H

    O

    CHCH2CH2N(CH3)2

    CHCH2CH2NHCH3 CHCH2CH2N(CH3)2

    AmitriptylineNortriptylineDoxepinNordoxepin

    H2N

    SNH

    OO ON

    CH3

    H3CO

    H3CO

    OCH3

    N

    N

    NH2

    NH2

    H2N

    SN

    OO

    N

    N

    CH3

    O

    O

    N COOHCH3

    O

    O

    NCH3 O

    O

    O

    O

    NCH3 O

    OCH3

    N

    NNH2

    Cl N

    HN

    O

    Cl

    OHN

    HN

    Desmethyldiazepam(Nordiazepam)

    O

    Cl N

    HN

    O

    Cl

    Chlordiazepoxide

    N

    NNHCH3

    Cl

    Demoxepam

    Benzoylecgonine Cocaine

    Cocaine andMetabolites

    Acid and Base

    Cocaethylene

    Oxazepam

    OOO

    CH3

    Sulfamethoxazole Trimethoprim Sulfmerazine

    Chlordiazepxideand Metabolites

    Norchlordiazepoxide

    Base

    Cheng

  • Copyright 1998 Waters Corporation

    Bases: Tricyclic Antidepressants

    Column: Symmetry® C18, 5 µm, 3.9 x 150 mm

    Temperature: 35°CMobile Phase: 20 mM Phosphate pH 7:

    Methanol (30:70)Detection: UV at 254 nmFlow Rate: 1.0 mL/min.Injection Volume: 20 µLSample Identification:

    Peak 1: Nordoxepin (I.S.)Peak 2: NortriptylinePeak 3: DoxepinPeak 4: Amitriptyline

    Compound Concentration % Recovery % RSD

    Nortriptyline 0.5 µg/mL 99.7 2.3

    Doxepin 0.5 µg/mL 94.0 1.3

    Amitriptyline 1.0 µg/mL 102 2.5

    5.00 10.0 15.0 20.0Minutes

    1

    2

    3

    4

    0.00

    6AU

    Cheng

  • Copyright 1998 Waters Corporation

    Results from the One-Dimensional SPE Method

    Using the one-dimensional SPE method, we were able to obtain excellent results for a wide range of compounds (concentration ranging between 40 ng/mL and 4.0 µg/mL) from a serum matrix:

    Recoveries all greater than 86%Reproducibility all less than 5.0%

  • Copyright 1998 Waters Corporation

    Two-Dimensional SPE Method

    Condition/Equilibrate1 mL methanol/1 mL water

    Prepare Sample Solution

    Load1 mL spiked sample solution

    Wash1 mL 5% methanol in water

    Washbase in methanol/water

    Eluteacid in methanol/water

    Washacid in methanol/water

    Elutebase in methanol/water

    Acids Bases

  • Copyright 1998 Waters Corporation

    Determination of % MeOH in 2-D SPE Method: Wash-Elute Study

    Condition/Equilibrate 20 Cartridges/Wells1 mL methanol/1 mL water

    Load1 mL spiked saline solution

    Prepare Analytes in Saline

    10 cartridges/wells 10 cartridges/wellsElute

    acid in various % methanol in waterElute

    base in various % methanol in water

    e.g. 2% NH4OH e.g. 2% HAc

  • Copyright 1998 Waters Corporation

    Wash-Elute Study (Antidepressants):

    0 20 40 60 80 100

    % MeOH

    0

    50000

    100000

    150000

    200000

    Are

    a (u

    V *

    sec

    )

    Wash (base)

    0 20 40 60 80 100

    % MeOH

    0

    50000

    100000

    150000

    Are

    a (u

    V *

    sec

    ) NordoxepinNortriptylineVerapamil, nor-MethylDoxepinAmitriptylineVerapamilVerapamil,Methoxy

    Elute (acid)

    Cheng

  • Copyright 1998 Waters Corporation

    Comparison of SPE Methods: Antidepressants in Plasma

    heng

    1

    1

    2

    2

    3

    34

    4 5

    5

    6

    7

    6

    7

    0.002 AU

    0.002 AU

    5 1510 Min.

    5 10 Min.15

    Sample

    SampleBlank

    One-Dimensional

    Two-Dimensional

    Blank

    Column: Symmetry® RP8, 5 µm 3.9 x 150 mm

    Temperature: 30°CMobile Phase: 100 mM Phosphate pH

    acetonitrile:methanol (55:35:10)

    Detection: UV at 230 nmFlow Rate: 1.0 mL/min.Injection Volume: 50 µL

    Sample Identification:Peak 1: Nordoxepin Peak 2: NortriptylinePeak 3: NorverapamilPeak 4: DoxepinPeak 5: AmitriptylinePeak 6: VerapamilPeak 7: Methoxyverapamil (I.S.)

  • Copyright 1998 Waters Corporation

    Results: Antidepressants

    Compound

    Concentration [µg/mL]

    Recovery(%)

    RSD (%)(n=6)

    Recovery(%)

    RSD(n=3)

    Amitriptyline 1.46 99.9 1.1 100.7 0.9

    Doxepin 1.0 98.4 0.7 114 3.3

    Nordoxepin 0.5 92.8 0.9 94.8 1.1

    Nortriptyline 0.62 95.3 1.3 97.7 0.2

    Verapamil 2.5 96.7 0.6 118 0.6

    Norverapamil 1.0 95.9 0.6 97.3 1.0

    Cheng

    2-Dimensional 1-Dimensional

  • Oasis™HLB Extraction Plates and Cartridges

  • Copyright 1998 Waters Corporation

    Prepare Sample1 mL spiked porcine serum

    Condition and equilibrate1 mL methanol and 1 mL water

    Load SampleWash

    1 mL 40% methanol containing 2% ammonium hydroxide

    Elute 500 µL 80% methanol containing 2% acetic acid

    Add 500 µL 2% ammonium hydroxide

    Oasis™ 96-Well Extraction Plate for High Throughput Analysis: Trazodone and Metabolite

    HN N

    Cl

    1-(3-Chlorophenyl)piperazine dihydrochloride

    NN

    N

    O

    N N

    Cl

    Trazodone

    Cheng

  • Copyright 1998 Waters Corporation

    Results from Oasis™ 96-Well Extraction Plate and Oasis™

    Extraction CartridgesRecoveries all greater than 88%Reproducibility all less than 5.6%

    Column: Symmetry® RP8, 5 µm, 3.9 x 150 mmTemperature: 30°CMobile Phase: 50 mM Phosphate pH 7: :methanol (36:64)Detection: UV at 250 nmFlow Rate: 1.0 mL/min.

    Injection Volume: 25 µLPeak 1: 1-(3-chlorophenyl)peperazinePeak 2: Maprotiline (I.S.)Peak 3: Trazodone

    0.01 AU

    1 654320minute

    1

    2

    3

    blank

    standard

    sample

    Cheng

  • Copyright 1998 Waters Corporation

    single moldsmaller lower stage for low bed masseslarger upper stage for high bed massescurrent bed configuration maintained

    30 mg10 mg 60 mg

    Low Elution VolumeWaters Proprietary* Two-Stage Well Design

    * patent pending

  • Copyright 1998 Waters Corporation

    Low Elut ion Volume Test Mixture: Acids , Neutrals, and Bases

    (Arranged from Most to Least Polar)

    Betamethasone ValerateO

    HO

    F

    OCO(CH2)3CH3

    OH

    O

    Betamethasone

    O

    HO

    F

    OHOH

    O

    HO

    HN

    O

    Acetaminophen Procainamide

    OS

    HN

    HN

    N

    CHNO2 H2N

    NH

    N

    O

    CH3

    CH3

    Ranitidine

    OHN

    OH

    Propranolol

    O

    CHCH2CH2N(CH3)2

    Doxepin

    O

    O

    O

    O

    Dipropyl Phthalate

  • Copyright 1998 Waters Corporation

    0 5 10 15

    ProcainamideRanitidineAcetaminophenTheophyllineBetamethasonePropranololDipropyl phth.DoxepinB-meth Val

    n = 8 wells

    Waters 10 mg Extraction Plate:% RSDs in 150 µL Elution Volume

    Waters 10 mg Plate

    3MC18-SD

  • Cop

    yrig

    ht 1

    998

    Wat

    ers

    Cor

    pora

    tion

    test

    Enalapril

    Enalapril -d5(IS)

    Enalaprilat

    Enalaprilat -d5(IS)

    PPD Pharmaco

    High Sensitivity DectectionEnalapril and Enalaprilat in Human Plasma (BLANKS)

  • Cop

    yrig

    ht 1

    998

    Wat

    ers

    Cor

    pora

    tion

    test

    0.25 ng/mLEnalapril

    5 ng/mLEnalapril -d5(IS)

    0.25 ng/mLEnalaprilat

    5 ng/mLEnalaprilat -d5(IS)

    PPD Pharmaco

    High Sensitivity DectectionEnalapril and Enalaprilat in Human Plasma

  • Copyright 1998 Waters Corporation

    Validated Method for Analysis of Enalapril in Human Plasma

    Concentration % Recoveryn=6

    Interday Precision, %CV

    n= 5 (x 2)

    Intraday Precision%CV n=6

    0.5 ng/mL 110.9 5.2 3.65 ng/mL 112.2 2.2 4.380 ng/mL 107.0 1.6 1.6

    Internal Std. 91.1

    PPD Pharmaco

  • Copyright 1998 Waters Corporation

    Validated Method for Analysis of Enalaprilat in Human Plasma

    Concentration % Recoveryn=6

    Interday Precision, %CV

    n= 5 (x 2)

    Intraday Precision%CV n=6

    0.5 ng/mL 103.6 5.2 3.05 ng/mL 109.4 3.4 3.280 ng/mL 104.5 1.7 1.2

    Internal Std. 94.3

    PPD Pharmaco

  • Copyright 1998 Waters Corporation

    SummaryUnique Sorbent

    No impact of dryingNo silanolsExtended pH rangeUniversal sorbent

    Fast and Easy Method Development

    One-dimensional methodSimple methodOne method, One result

    Two-dimensional methodStraightforward methodCleaner extracts